Related Experiment Video
Updated: Aug 12, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
Relationship between the shape of dose-response curves and background tumor rates
1National Center for Toxicological Research, Jefferson, Arkansas 72079.
Abstract:
Various authors have argued that a chemical which augments a carcinogenic process, which is already producing tumors spontaneously, will produce an increase in tumors no matter how small the dose. For this situation, no threshold dose exists whether or not the chemical is genotoxic. Under such conditions, it is expected that the dose-response will contain a linear term. A large database of animal bioassays (Gold et al., 1984) was examined to study the relationship between the shape of dose-response curves and the background tumor rate. The multistage model was fit to 143 data sets from 75 different chemicals. As expected, the presence of the linear term was correlated with the background tumor rate and the presence of higher degree terms in dose (cubic or greater) decreased as the background rate increased. This examination of a large number of chronic bioassay results appears to support the premise that low dose linearity is generally expected for tumor sites where background tumors occur, even for carcinogens which were negative by the Salmonella genotoxicity test.
More Related Videos
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
Related Concept Videos
Dose-Response Relationship: Overview
Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Dose Response Curve: Conventional Versus Nonmonotonic